This study developed a biodegradable dissolvable face mask incorporating liposomal kojic acid (KA) and licochalcone A from licorice extract (LE) to enhance skin delivery and performance. Liposomes were prepared by thin-film hydration method. The film matrix, composed of PVA/PVP/PEG400/HA, was optimized using factorial design to achieve suitable mechanical strength and rapid dissolution. The optimized mask, containing liposomal KA (1% w/v) and licochalcone A (0.025% w/v), was evaluated for antioxidant activity, ex vivo skin deposition, and short-term efficacy (Approval from the Institutional Review Board of Silpakorn University, Thailand; Ethics Approval No. REC 67.1001-146-7726/COA 68.0320-013 Date of registration: 20 March 2025). The optimized liposomes exhibited a mean particle size of 66–72 nm, entrapment efficiency above 65%, and a zeta potential of −12.5 mV (licochalcone A) and −1.67 mV (KA). Liposomal licochalcone A and KA showed potent antioxidant activity compared to their native forms. The optimized film dissolved within approximately 15 min on moist skin and showed favorable handling properties. Ex vivo studies revealed significantly higher skin deposition of both KA and licochalcone A from the liposomal mask compared with free and liposomal dispersions (p < 0.05). In a 7-day clinical evaluation, the mask significantly improved skin hydration and reduced melanin index (p < 0.05). No irritation or adverse reactions were observed, and user satisfaction was high. This liposomal dissolvable mask offered an effective, well-tolerated, and eco-friendly approach to enhancing skin brightness and hydration, supporting its potential as a sustainable cosmeceutical innovation.
Taesotikul et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: